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Introduction
Chronic obstructive pulmonary disease (COPD) is a major 
cause of disability and premature death and as a result is 
regarded as global health priority.7 While the relative contri-
bution of coronary heart disease and stroke towards death 
is on the decline, mortality from COPD is on the increase.17 
This trend has prompted an increase in the number of stud-
ies investigating the efficacy of different treatment modalities 
within pulmonary rehabilitation (PR), and has resulted in the 
synthesis of a number of consensus statements and clinical 
guidelines by various associations. 
PR can be defined as ‘an evidence-based multidisciplinary 
and comprehensive intervention for patients with chronic 
respiratory disease who are symptomatic and often have 
decreased daily life activities. Integrated into individualised 
treatment of the patient, pulmonary rehabilitation is designed 
to reduce symptoms, optimise functional status, increase 
participation, and reduce health care costs through stabilising 
or reversing systemic manifestations of the disease.37 A 
number of deleterious effects have been associated with 
COPD and include, among others, social isolation, exercise 
deconditioning, depression, muscle wasting and impaired 
health-related quality of life (HRQL). 9,55,56  Consequently, 
PR programmes should aim to treat the patient holistically. 
This invariably means adopting an interdisciplinary approach 
where various health care professionals address the different 
components represented in Fig. 1. 
CoMMENTARY
CoPD:	Is	there	evidence	to	support	a	role	for	resistance	
training	in	improving	measurable	health-related	quality	of	
life	in	pulmonary	rehabilitation?	
Abstract
Chronic obstructive pulmonary disease (COPD) is one of 
the leading causes of morbidity and mortality. As such, the 
disease places a significant burden on health care serv-
ices. Although the pathogenesis of COPD is complex, 
progressive airflow limitation and a chronic inflammatory 
response are two hallmark characteristics of the disease. 
In addition, systemic manifestations such as peripheral 
muscle dysfunction have recently received considerable 
attention in the literature. Pulmonary rehabilitation is an 
evidence-based multidisciplinary intervention that has 
been shown to produce clinically relevant outcomes. One 
important component of rehabilitation is exercise. With the 
majority of COPD patients presenting with muscle weak-
ness and exercise intolerance, the inclusion of resistance 
training into a pulmonary rehabilitation programme would 
seem appropriate. Compared with other exercise/training 
modalities only a small number of studies have investigat-
ed the effects of resistance training in COPD patients. Al-
though further research is required to identify the optimal 
mode, intensity and frequency, it appears that resistance 
training may prove to be a valuable intervention for COPD 
patients enrolled in pulmonary rehabilitation programmes.
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COPD pathophysiology 
COPD is ‘a disease state characterised by airflow limitation 
that is not fully reversible. The airflow limitation is usually 
both progressive and associated with an abnormal inflam-
matory response of the lungs to noxious particles or gases’.35 
Noxious stimuli such as viral infections and inhaled irritants, 
especially cigarette smoking, results in irritation of the res-
piratory tract mucosa. It has been suggested that this con-
tinual irritation induces epithelial injury and thus provides the 
stimulus for inflammatory infiltrate.11 Dominance of a chronic 
inflammatory state within the mucosa results in mucus hyper-
secretion, ciliary dysfunction, oedema and structural changes 
such as fibrosis and loss of parenchymal integrity. 38,45 The 
resultant swelling of the mucosa and subsequent narrowing 
of the lumen result in airflow obstruction and air trapping/hy-
perinflation. The inhibition of normal gaseous exchange, i.e. 
impaired lung function, results in hypoxaemia, which in turn 
induces dyspnoea, a factor that may deter patients from par-
ticipating in physical activity.1,10 
Skeletal muscle dysfunction
Inflammatory sequelae are central to the pathogenesis of 
COPD, and while it has traditionally been defined as a dis-
ease of the airways, significant systemic factors manifest in 
COPD patients, making it a multi-component disease.60 A 
common finding in patients suffering from COPD is muscle 
weakness and a reduction in muscle mass.3,23,45  It appears 
that lower limb muscles are more affected than those of the 
upper limbs.3,23 Potential factors contributing to muscle wast-
ing in COPD patients are represented in Fig. 2. It should be 
noted that these factors may all contribute in varying degrees 
towards skeletal muscle dysfunction. The reduction in fat free 
mass in COPD patients may negatively impact on ‘physical 
function, health status and survival’.25 Recently, muscle dys-
function has received considerable attention within the litera-
ture as a hallmark manifestation of COPD. Skeletal muscle 
comprises approximately 73% of body mass.31 In addition to 
affecting HRQL, dysfunction of skeletal muscle has impor-
tant implications for exercise tolerance and physical rehabili-
tation. Physiological or structural alterations that have been 
documented in the skeletal muscle of COPD patients include: 
increased proportion of type II fibres;47 reductions in myosin 
heavy chain type I isoforms;34 reductions in uncoupling pro-
tein-3LmRNA (protects against mitochondrial damage) and 
intramyocellular triglyceride in oxidative fibres;46 reduced 
vastus lateralis mitochondrial density;18 reductions in cross-
sectional area of type IIX fibres and increased fibrosis;19 re-
ductions in oxidative enzymes  (correlated with number of 
type I fibres) and lowered oxidative capacity in type II fibres;20 
decreased muscle capillarity26 and  reductions in peroxisome 
proliferator-activated receptors (involved in mitochondrial 
biogenesis).43 Gosker et al. 21 recently confirmed that the se-
verity of COPD is associated with reductions in the propor-
tion of type I fibres. The aforementioned factors together with 
the finding that lactic acidosis occurs earlier during exercise 
in COPD patients compared with healthy subjects,33 may 
partly explain why COPD patients fatigue quicker and experi-
ence exercise intolerance. This in turn may deter individuals 
from participating in physical activity and promote physical 
deconditioning, ultimately fuelling the progression of COPD 
(Fig. 3). 
Exercise  and  pulmonary rehabilitation
Pulmonary rehabilitation (PR) programmes can improve 
HRQL in COPD patients.12 Exercise intervention is argu-
ably one of the most important components of a PR pro-
gramme.30,37,44,57,58  Exercise intolerance in COPD patients 
cannot be solely attributed to ventilatory limitations.52  Rather, 
it has been proposed that the limitations are multifactorial and 
include metabolic and gas exchange abnormalities, periph-
eral muscle dysfunction, cardiac impairment and exertional 
symptoms.39  A number of studies have shown the positive 
effects that exercise training may exert on a variety of clini-
cal symptoms in COPD patients. The mode of exercise most 
extensively researched has been that of endurance/aerobic 
type activities. In addition, a substantial number of investiga-
tions have been conducted into the effects of inspiratory and 
expiratory ventilatory training in COPD patients. Although 
most COPD patients experience muscle weakness, compar-
atively fewer studies have investigated resistance-training 
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Fig. 2. Factors involved in muscle wasting in COPD 
(adapted from Jagoe and Engelen(25)).
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effects in COPD patients as a modality in isolation. To the 
best of the authors' knowledge Table I contains the only stud-
ies that have documented the effects of resistance training 
in COPD patients. Some of these studies compared a re-
sistance training group versus other interventions. However, 
the alterations summarised in Table I represent the effects of 
only resistance training and no other combined intervention. 
COPD is not just a disease of the respiratory system. It 
is now well established that the skeletal muscles of COPD 
patients are both morphologically and functionally different 
from those of healthy individuals.19 The extent of the changes 
is so pronounced that COPD has been termed a muscle 
disease.57 Since exercise intolerance in COPD cannot be 
attributed to ventilatory limitations alone, and skeletal muscle 
TABLE I. Effects of resistance training on selected variables in COPD patients
Reference Participants  Intervention    Significant alterations (p<0.05)
Simpson et al.
49 
COPD patients (N=14, Weightlifting 3x/wk for 8 wks 3 x 10 reps;  Increased patients’ mastery over the
   mean FEV1 39.5% predicted,  workload increased from 50% of 1RM  demands of daily living. Improvements
   mean age 73 years)  in week 1 to 85% of 1RM in week 8;  in fatigue and dyspnoea; time to fatigue
      1RM re-evaluated every 6 session;  during cycling at 80% of maximum
      single arm curl, leg press and leg extension improved; 1RM improvements in arm
           curl (33%), leg press (16%) and leg
           extension (44%) 
Clark et al.
8 
COPD patients (N=26,  Dynamic weight training exercises  Increases in maximum weight lifted
    mean FEV1 76%   (N=8). 2x/wk for 12 wks; workload  (isotonic) observed for 5 out of the
   predicted, mean age 51  70% of 1RM for 12 wks; after week 6,  8 exercises; sustained (60s) isokinetic
   years)   1RM assessed and workload   muscle work, endurance work (joules)
      adjusted to ‘new’ 70%; upper and  and maximal tidal volume improved
      lower body exercises
Spruit et al. 
50 
COPD patients (N=24,  Dynamic strengthening exercises  Increases in knee extension, knee
   mean FEV1 40%  (machines & pulleys). 3x/wk for 12  flexion, shoulder abduction, and
   predicted, mean age 64  wks; initial intensity 70% of 1RM (3 x  elbow flexion force; 38% improvement
    years)   8 reps); weekly ↑ 5% of 1 RM   in 6MWD; increased peak watts during
           an incremental cycling test; improved 
           HRQL
Ortega et al. 
40 
COPD patients (N=17,  Dynamic strengthening exercises  Shuttle walking test (m) and endurance
   mean FEV1 40%  (‘gymnastics apparatus’) 3x/wk for 12  test (min) improved; strength
   predicted, mean age 66  wks; 4 x 6-8 reps, 70-85% of 1RM  measurements (kg) in chest pull,
   years)   RM testing conducted every 2   butterfly, neck press, leg flexion and
      wks to adjust workload; upper and  leg extension improved; dyspnoea
         lower body exercises    and HRQL improved
Wright et al.
 61 
COPD patients (N=20,  Upper and lower body dynamic strength/machine Cycle ergometry performance 
   mean FEV1 54% predicted,  exercises 2x/wk for 2wks; 3 x 12 reps (adaptation improved in training group
   mean age 56 years)  phase – submaximal intensity), then 3x/wk  (18.7%); improved HRQL
      2-4 x 10 reps, for 5 wks, then 3/wk 2-4 x 8-10 reps    
      for 5 wks (focus on intensive eccentrics)  
Kongsgaard et al. 
29 
COPD patients (N=6,  Progressive resistance training 2x/wk  ADL (walking 400 m, climbing stairs,
   mean FEV1 48% predicted, for 12 wks; 4 x 8 reps (2-3min between sets), carrying 5 kg) improved; self-reported
   mean age 71 years)  80% of 1RM; leg press, knee extension,  health improved, knee extension
      knee flexion; workload adjusted weekly  and trunk flexion strength improved,
           gait time (30 m) and stair climbing
            time decreased
Hoff et al. 
24 
COPD patients (N=6,  Horizontal leg press, 8 wk (24 sessions);  Dynamic rate of force development,
   mean FEV1 32% predicted, 4 x 5 reps, 85-90% of 1RM; 2.5 kg progressions 1RM and peak static force improved;
   mean age 62 years)  implemented when subject could  mechanical efficiency of cycling
      perform more than 5 reps   (40W) improved by 31%; RPE at
            40W reduced; improved FEV1 (21%),  
           FVC 
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dysfunction is a significant component of the disease, it would 
seem appropriate to incorporate resistance training into a 
PR programme. Resistance training ‘involves the voluntary 
activation of specific skeletal muscles against some form of 
external resistance, which is provided by body mass, free 
weights (barbells and dumbbells), or a variety of exercise 
modalities (machines, springs, elastic bands, manual 
resistance etc.)’. 59 The potential benefits of resistance 
training in apparently healthy individuals have been reviewed 
by a number of authors, and includes improvements in muscle 
strength, increases in muscle size (hypertrophy), increases in 
protein synthesis, reductions in visceral fat, and reductions in 
risk factors associated with chronic disease such as diabetes, 
cardiovascular disease, cancer and osteoporosis.14,59 The 
latter may prove beneficial for COPD patients, as many suffer 
from co-morbid conditions. 
It is arguable that any intervention employed within a PR 
programme should directly or indirectly serve to improve the 
patient’s quality of life. With this in mind, the question should 
be asked: do improvements in strength conferred from 
resistance training translate to improvements in functional 
capacity in COPD patients? There is evidence to support the 
value of resistance training in reducing functional limitations in 
healthy individuals.5 From the randomised controlled studies 
summarised in Table I, it is apparent that strength of specific 
muscles improved in 6 out of 6 of the studies in which it was 
measured. In addition, improved activities of daily living, the 
mastery thereof, and/or HRQL were significantly enhanced 
in 5 of the 7 studies. HRQL is most commonly measured 
using the Chronic Respiratory Disease Questionnaire.22 
The questionnaire, which has been validated for use in 
a clinical setting, measures four categories pertaining to 
physical and emotional discomfort during normal daily 
activities. The patient’s responses are scored on a 7-point 
Likert scale for categories of dyspnoea, fatigue, emotional 
function and mastery. Although the interventions among the 
studies differed, all used patients with COPD. It remains to 
be seen what effect resistance training may have on patients 
who have other pulmonary conditions/disorders. All the 
studies implemented the principle of progression and the 
training intensity was based on nothing ‘lighter’ than 70% of 
the subject’s one repetition maximum.  No authors reported 
adverse effects of the training despite some interventions 
being of a high intensity (≥85% of 1RM). Improvements in 
maximal tidal volume and FEV1 in the studies by Clark et 
al.8 and Hof et al.24 respectively, were the only documented 
changes in pulmonary function parameters. Although FEV1 
is important in the diagnosis of COPD, it cannot be reliably 
correlated with exercise capacity, dsypnea or HRQL.10 Thus, 
the lack of improvements in pulmonary function parameters 
following resistance training interventions may not be clinically 
significant. A potential limiting factor in terms of interpreting 
the efficacy of resistance training in the PR programmes 
referenced in Table I is that there are large discrepancies in 
the ages of the participants. In addition, the studies fail to 
indicate what the participant’s level of activity and co-morbid 
status was before being diagnosed with COPD. This implies 
that the participants utilised in the studies may have shown 
favourable benefits from the training interventions because 
they may have been sedentary (or active) for many years 
prior to their diagnosis. Thus, the ‘true’ benefits conferred by 
the resistance training are difficult to quantify accurately.   
More studies have been conducted on the effects of 
endurance training in PR than any other modality.9 In addition 
to the studies referenced in Table I, a number of researchers 
have looked at a combination of strength-endurance 
interventions in COPD patients.2,4,3,28,32 Results from these 
studies do in some instances support a combined programme 
over endurance or resistance training alone. The reported 
additive effects of combined interventions (resistance and 
endurance) in some studies have gained support for its 
incorporation into rehabilitation programmes.4,28,37,56 When 
summarising randomised controlled trials comparing different 
exercise modes on COPD patients, Puhan et al.42 reported 
that ‘strength exercise led to larger improvements of HRQL 
than endurance exercise’. Although only 4 studies (strength v. 
endurance) were compared for the purposes of the review, the 
results do highlight the potential therapeutic value of strength/
resistance training. An advantage of resistance training is that 
it stresses the cardiorespiratory system less when compared 
with traditional aerobic exercise (cycling, walking, jogging). 
The reduced metabolic demand of resistance training means 
lower levels of lactate accumulation and dyspnoea, factors 
that would encourage patients to adhere to physical training 
interventions.
Resistance training and molecular adaptations in 
skeletal muscle
It may be counter-intuitive to recommend resistance training 
to COPD patients due to the shift from a slow to fast twitch 
phenotype, observed in their skeletal muscle.21,34,47  A shift 
in distribution from slow to fast twitch fibres gives rise to 
altered activities of key oxidative and glycolytic enzymes62 
that may decrease oxidative capacity and increase the risk 
of developing insulin resistance.48 Whether resistance train-
ing exacerbates this phenotype switch, decreasing functional 
and oxidative capacity further, or maintains the status quo, 
has not been determined in COPD patients. In addition, it 
was recently hypothesised that resistance training may only 
induce brief 5’AMP-activated protein kinase (AMPK) activa-
tion (possibly not at all), resulting in limited AMPK-depend-
ent adaptations such as mitochondrial biogenesis.51 With the 
skeletal muscle of COPD patients already exhibiting reduced 
mitochondrial biogenesis, oxidative enzymes and oxidative 
capacity,18,43 the possibility that resistance training may ex-
acerbate this situation requires clarification.
In contrast to the above possible detrimental effects 
of resistance training for COPD patients, recent research 
has shown that acute resistance training promotes skeletal 
muscle angiogenesis and hence capillarity.6,16,54  This 
finding provides support for the use of resistance training in 
COPD patients, who display decreased muscle capillarity.26 
Specifically, research has shown that vascular endothelial 
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growth factor (VEGF) mRNA is increased 2.9-fold above rest 
24 hours after resistance exercise in young and aged men 
as determined by pooled mRNA microarray analysis.27 In the 
most recent study, acute resistance exercise (3 sets of 10 
repetitions knee extension at 60 - 80% of 1 RM, 2 minutes’ 
rest between each set) significantly increased skeletal 
muscle (vastus lateralis) VEGF mRNA and protein, plasma 
VEGF protein and skeletal muscle VEGF receptor (KDR and 
Nrp1) mRNA in sedentary, young (range 24 - 32 years of 
age) individuals (6 men, 1 woman). The authors concluded 
that early angiogenic signalling for VEGF is increased by 
acute resistance exercise although additional research is 
required to determine the signal transduction pathways 
responsible for up-regulating the angiogenesis growth factors 
and receptors.16 It remains to be determined whether the 
increased skeletal muscle angiogenesis/capillarity induced 
by resistance training in healthy young individuals also 
occurs in COPD patients, who are typically older. In addition, 
research is also required to determine whether resistance 
training induced increases in skeletal muscle angiogenesis/
capillarity has any beneficial effect on the functional capacity 
and HRQL of COPD patients.
Anti-inflammatory nature of resistance training?
From the above discussion it can be seen that the precise 
molecular mechanisms in skeletal muscle that may under-
lie beneficial or detrimental resistance training transfers for 
PR patients are complex, with many areas requiring further 
research.
An additional area of research that is currently receiving 
worldwide attention relates to the possible anti-inflammatory 
effect of exercise. With COPD exhibiting a strong inflammatory 
component,35 it may just be that exercise serves to attenuate 
the chronic inflammatory response in these patients. 
Oxidative stress (free radical species) modulates aspects of 
inflammatory-induced alterations in skeletal muscle function.53  
Eight weeks of aerobic exercise (cycle ergometry) 3 times 
per week for 60 minutes has been shown to reduce exercise-
induced oxidative damage in COPD patients.41 Exercise-
induced elevations in cytokines (particularly interleukin-6) 
have been implicated as potential role players involved 
in inducing the anti-inflammatory effect associated with 
exercise.15 Whether resistance training promotes a down-
regulation in oxidative/inflammatory responses remains to be 
elucidated. High doses of corticosteroids have been shown 
to induce skeletal myopathies.36 If indeed the mechanism 
by which exercise imparts favourable health benefits is anti-
inflammatory sequelae, then it may reduce or impact on the 
patient’s reliance on medications. This in turn could affect 
HRQL as certain medications have undesirable side-effects. 
Conclusion
Although guidelines have been established,52 the optimal 
mode, frequency and intensity of resistance training (espe-
cially among differing pulmonary pathologies) still requires 
further investigation. This is important in order to establish the 
true efficacy of resistance training for COPD patients. This in 
turn would prevent rehabilitation practitioners from prescrib-
ing to or implementing practices that are not supported by 
evidence. Recently, evidence-based clinical guidelines joint-
ly generated by the American College of Chest Physicians 
(ACCP) and the American Association of Cardiovascular 
and Pulmonary Rehabilitation (AACVPR) reject the inclusion 
of inspiratory training as part of a PR programme based on 
lack of evidence.44 This highlights the fact that although pa-
pers have been published advocating the use of inspiratory 
training in COPD patients, further research is still required. 
Similarly, further research is still required to show that resist-
ance training may reduce and/or reverse muscle wasting and 
dysfunction. Currently, no studies have been conducted in 
which muscle biopsies have been performed to determine 
if cellular/biochemical changes occur as a result of strength 
training in COPD patients.44  
Based on the results of studies that have investigated the 
effects of resistance training on COPD patients, it seems 
that resistance training may indeed contribute favourably 
to the exercise training component within a PR programme. 
This ‘sentiment’ is acknowledged by the ACCP and the 
AACVPR. Although ‘clinicians underestimated the degree 
to which skeletal muscle weakness contributes to patient 
morbidity’.53 it seems that within the literature more and more 
authors are promoting the inclusion of resistance training 
within PR programmes. Many argue that a combination of 
endurance and strength training would be most beneficial for 
the patient. Future studies are required to shed light on the 
extent to which resistance training may impact on functional 
capacity and HRQL in COPD patients. In addition, studies 
are required to investigate the role of resistance training 
in altering inflammatory responses as well as beneficial or 
detrimental molecular pathways within the skeletal muscle of 
COPD patients.
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